ACUTUS MEDICAL INC (AFIB) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:AFIB • US0051111096

0.09 USD
-0.03 (-26.83%)
At close: May 8, 2024
0.06 USD
-0.03 (-33.33%)
After Hours: 5/8/2024, 8:00:00 PM
Fundamental Rating

2

Overall AFIB gets a fundamental rating of 2 out of 10. We evaluated AFIB against 186 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of AFIB have multiple concerns. AFIB is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year AFIB has reported negative net income.
  • In the past year AFIB has reported a negative cash flow from operations.
  • AFIB had negative earnings in each of the past 5 years.
  • AFIB had a negative operating cash flow in each of the past 5 years.
AFIB Yearly Net Income VS EBIT VS OCF VS FCFAFIB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -20M -40M -60M -80M -100M

1.2 Ratios

  • AFIB's Return On Assets of -111.27% is on the low side compared to the rest of the industry. AFIB is outperformed by 83.94% of its industry peers.
Industry RankSector Rank
ROA -111.27%
ROE N/A
ROIC N/A
ROA(3y)-83.45%
ROA(5y)-79.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AFIB Yearly ROA, ROE, ROICAFIB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 2K 4K 6K 8K

1.3 Margins

  • AFIB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AFIB Yearly Profit, Operating, Gross MarginsAFIB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 -1K -2K -3K

2

2. Health

2.1 Basic Checks

  • AFIB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • AFIB has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, AFIB has a worse debt to assets ratio.
AFIB Yearly Shares OutstandingAFIB Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
AFIB Yearly Total Debt VS Total AssetsAFIB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -19.03, we must say that AFIB is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of AFIB (-19.03) is worse than 86.01% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -19.03
ROIC/WACCN/A
WACC11.53%
AFIB Yearly LT Debt VS Equity VS FCFAFIB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 50M -50M 100M -100M

2.3 Liquidity

  • AFIB has a Current Ratio of 2.44. This indicates that AFIB is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of AFIB (2.44) is worse than 64.25% of its industry peers.
  • A Quick Ratio of 2.22 indicates that AFIB has no problem at all paying its short term obligations.
  • AFIB has a Quick ratio (2.22) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 2.22
AFIB Yearly Current Assets VS Current LiabilitesAFIB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 50M 100M 150M

6

3. Growth

3.1 Past

  • AFIB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.71%, which is quite impressive.
  • AFIB shows a decrease in Revenue. In the last year, the revenue decreased by -5.21%.
  • Measured over the past years, AFIB shows a very strong growth in Revenue. The Revenue has been growing by 79.26% on average per year.
EPS 1Y (TTM)34.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.72%
Revenue 1Y (TTM)-5.21%
Revenue growth 3Y79.26%
Revenue growth 5YN/A
Sales Q2Q%-12.95%

3.2 Future

  • AFIB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.68% yearly.
  • AFIB is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 59.26% yearly.
EPS Next Y12.16%
EPS Next 2Y15.17%
EPS Next 3Y13.68%
EPS Next 5YN/A
Revenue Next Year31.1%
Revenue Next 2Y41.69%
Revenue Next 3Y46.08%
Revenue Next 5Y59.26%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AFIB Yearly Revenue VS EstimatesAFIB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
AFIB Yearly EPS VS EstimatesAFIB Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -5 -10 -15

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AFIB. In the last year negative earnings were reported.
  • Also next year AFIB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AFIB Price Earnings VS Forward Price EarningsAFIB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AFIB Per share dataAFIB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

  • AFIB's earnings are expected to grow with 13.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.17%
EPS Next 3Y13.68%

0

5. Dividend

5.1 Amount

  • AFIB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ACUTUS MEDICAL INC / AFIB FAQ

What is the fundamental rating for AFIB stock?

ChartMill assigns a fundamental rating of 2 / 10 to AFIB.


Can you provide the valuation status for ACUTUS MEDICAL INC?

ChartMill assigns a valuation rating of 0 / 10 to ACUTUS MEDICAL INC (AFIB). This can be considered as Overvalued.


How profitable is ACUTUS MEDICAL INC (AFIB) stock?

ACUTUS MEDICAL INC (AFIB) has a profitability rating of 0 / 10.


Can you provide the financial health for AFIB stock?

The financial health rating of ACUTUS MEDICAL INC (AFIB) is 2 / 10.